Synthesis and vasorelaxant evaluation of novel 7-methoxyl-2,3-disubstituted-quinoxaline derivatives

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people

Eleni Rapsomaniki, Adam Timmis, Julie George et al. · The Lancet · 2014 · 1.6K citations · Full text

Medicine, Cardiology, Clinical Epidemiology +15

Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines

Ajit K Parhi, Yong‐Zheng Zhang, Kurt W. Saionz et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 166 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Cardiovascular Diseases and Risk‐Factor Burden in Urban and Rural Communities in High‐, Middle‐, and Low‐Income Regions of China: A Large Community‐Based Epidemiological Study

Ruohua Yan, Li Wei, Yin Lu et al. · Journal of the American Heart Association · 2017 · 113 citations · Full text

Public Health, Cardiology, Health Sciences +17

Design and Synthesis of Small Molecule RhoA Inhibitors: A New Promising Therapy for Cardiovascular Diseases?

Jing Deng, Enguang Feng, Sheng Ma et al. · Journal of Medicinal Chemistry · 2011 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors

Lei You, Eun Jeong Cho, John M. Leavitt et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 45 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14